CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
NUGIX
Price
$35.81
Change
+$0.11 (+0.31%)
Updated
Jun 6 closing price
Net Assets
18.93M
Interact to see
Advertisement

CWGCX vs NUGIX

Header iconCWGCX vs NUGIX Comparison
Open Charts CWGCX vs NUGIXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
Nuveen Global Dividend Growth I
Price$35.81
Change+$0.11 (+0.31%)
VolumeN/A
Net Assets18.93M
CWGCX vs NUGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. NUGIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and NUGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. NUGIX (18.9M). NUGIX pays higher dividends than CWGCX: NUGIX (1.30) vs CWGCX (0.87). CWGCX was incepted earlier than NUGIX: CWGCX (24 years) vs NUGIX (13 years). NUGIX (1.58) is less costly to investors than CWGCX (1.49). CWGCX is a more actively managed with annual turnover of: 27.00 vs. NUGIX (17.00). CWGCX has a lower initial minimum investment than NUGIX: CWGCX (250) vs NUGIX (100000). CWGCX annual gain was more profitable for investors over the last year : 5.53 vs. NUGIX (5.15). CWGCX (42.30) and NUGIX (40.82) have equivalent 5 years return.
CWGCXNUGIXCWGCX / NUGIX
Total Expense Ratio1.490.90166%
Annual Report Gross Expense Ratio1.491.5894%
Fund Existence24 years13 years-
Gain YTD8.7113.968220%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets131B18.9M693,122%
Annual Yield % from dividends0.871.3067%
Returns for 1 year5.535.15107%
Returns for 3 years26.8621.43125%
Returns for 5 years42.3040.82104%
Returns for 10 years49.3150.3498%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.